• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种自动化工作流程的高通量HPV检测性能分析

Performance analysis of high-throughput HPV testing on three automated workflows.

作者信息

Loonen Anne J M, Huijsmans Cornelis J J, Geurts-Giele Willemina R R, Leeijen Cindy, van der Linden Johannes C, van den Brule Adriaan J C

机构信息

Pathologie-DNA, Lab for Molecular Diagnostics, Location Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.

Department of Applied Natural Sciences, Section Diagnostics and Test Development, Fontys University of Applied Sciences, Eindhoven, The Netherlands.

出版信息

APMIS. 2020 Aug;128(8):497-505. doi: 10.1111/apm.13064.

DOI:10.1111/apm.13064
PMID:32562292
Abstract

Primary high-risk human papillomavirus (hrHPV) DNA testing has been introduced in several countries worldwide, including The Netherlands. The objective of this study was to compare three automated workflow procedures for hrHPV testing of which the hrHPV detection assays meet the international guidelines for HPV testing. To mimic a realistic screening situation, we aimed to process 15 000 residual PreservCyt cervical samples in a period of 3 months. During a 3 months period, four technicians were involved in processing 5000 specimens per month on three automated platforms, (1) Qiagen Digene® HC2 HPV DNA test (HC2, signal amplification); (2) Roche Cobas® HPV test (DNA amplification), and (3) Hologic Aptima® HPV test (RNA amplification). We measured and scored general aspects (time-to-results, hands-on-time (HOT)), maintenance, pre-run, run and post-run aspects, inventory (orders, storage), and number of errors on a scale from 1 to 10. As determined for one complete workflow each, maximum processing capacity and HOT were 296 samples and 2 h:55 m, 282 samples and 3 h:20 m, and 264 samples and 4 h:15 m for Aptima, Cobas, and HC2, respectively. The mean throughput time per run was 5 h:51 m for Cobas in which 94 samples could be processed. For Aptima, the mean throughput time per run was 6 h:30 m for 60 samples. Mean throughput time for HC2 is longer since results were provided on day 2. In this study, the fully automated Aptima workflow scores best with a 7.2, followed by Cobas with a score of 7.1 and HC2 with a score of 5.8. Although all HPV tests used in this comparison meet the international test guidelines, the performance (workflow) characteristics of the assays vary widely. A specific choice of a laboratory for high-throughput testing can be different based on the laboratory's demands, but also hands-on-time, time-to-results/ # samples, maintenance, pre-run, run and post-run parameters, consumables, technical support, and number of errors are important operational factors for the selection of a fully automated workflow for hrHPV testing.

摘要

包括荷兰在内,全球已有多个国家引入了原发性高危型人乳头瘤病毒(hrHPV)DNA检测。本研究的目的是比较三种hrHPV检测的自动化工作流程程序,其中hrHPV检测分析符合HPV检测的国际指南。为模拟实际筛查情况,我们旨在3个月内处理15000份剩余的PreservCyt宫颈样本。在3个月的时间里,四名技术人员参与在三个自动化平台上每月处理5000份样本,(1)Qiagen Digene® HC2 HPV DNA检测(HC2,信号放大);(2)罗氏Cobas® HPV检测(DNA扩增),以及(3)Hologic Aptima® HPV检测(RNA扩增)。我们对一般方面(出结果时间、实际操作时间(HOT))、维护、运行前、运行中和运行后方面、库存(订单、存储)以及错误数量进行了1至10分的测量和评分。就每个完整工作流程而言,Aptima、Cobas和HC2的最大处理能力和HOT分别为296个样本和2小时55分钟、282个样本和3小时20分钟以及264个样本和4小时15分钟。Cobas每次运行的平均通量时间为5小时51分钟,可处理94个样本。对于Aptima,每次运行60个样本的平均通量时间为6小时30分钟。HC2的平均通量时间更长,因为结果在第2天提供。在本研究中,全自动Aptima工作流程得分最高,为7.2分,其次是Cobas,得分为7.1分,HC2得分为5.8分。尽管本比较中使用的所有HPV检测均符合国际检测指南,但各检测分析的性能(工作流程)特征差异很大。根据实验室的需求,高通量检测实验室的具体选择可能会有所不同,但实际操作时间、出结果时间/样本数量、维护、运行前、运行中和运行后参数、耗材、技术支持以及错误数量也是选择hrHPV检测全自动工作流程的重要操作因素。

相似文献

1
Performance analysis of high-throughput HPV testing on three automated workflows.三种自动化工作流程的高通量HPV检测性能分析
APMIS. 2020 Aug;128(8):497-505. doi: 10.1111/apm.13064.
2
HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.荷兰宫颈癌筛查人群中的人乳头瘤病毒流行情况(DuSC研究):使用自动化HC2、cobas和Aptima工作流程进行人乳头瘤病毒检测
BMC Cancer. 2016 Nov 28;16(1):922. doi: 10.1186/s12885-016-2961-2.
3
Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.比较 ATHENA 研究中 cobas® HPV Test 检测结果在低阳性范围内的杂交捕获 2 高危型 HPV 的结果。
J Clin Virol. 2013 Sep;58(1):161-7. doi: 10.1016/j.jcv.2013.06.041. Epub 2013 Jul 27.
4
HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system.用于宫颈癌筛查的HPV检测:实验室物流的技术改进以及cobas 6800与4800系统相比的良好临床性能
BMC Womens Health. 2019 Mar 25;19(1):47. doi: 10.1186/s12905-019-0743-0.
5
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.有关人乳头瘤病毒检测在宫颈癌二级预防中的证据。
Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095.
6
Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.基于人群的加拿大不列颠哥伦比亚省女性特定型别 HPV 流行率评估。
Vaccine. 2013 Feb 4;31(7):1129-33. doi: 10.1016/j.vaccine.2012.09.085. Epub 2012 Dec 25.
7
Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.在因巴氏细胞学检查发现意义不明确的非典型鳞状细胞而转诊进行阴道镜检查的女性人群中,比较Aptima人乳头瘤病毒检测法与cobas人乳头瘤病毒检测法检测人乳头瘤病毒的情况。
J Clin Microbiol. 2015 Apr;53(4):1277-81. doi: 10.1128/JCM.03558-14. Epub 2015 Feb 4.
8
Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross-contamination.比较 PreservCyt 标本原始瓶与复瓶 cobas 人乳头瘤病毒检测结果,并评估潜在的交叉污染。
Cancer Cytopathol. 2012 Dec 25;120(6):380-9. doi: 10.1002/cncy.21213. Epub 2012 Jun 20.
9
Human papillomavirus detection with genotyping by the cobas and Aptima assays: Significant differences in HPV 16 detection?采用 cobas 和 Aptima 检测法进行人乳头瘤病毒检测及基因分型:HPV 16 检测存在显著差异?
Diagn Cytopathol. 2018 Jul;46(7):568-571. doi: 10.1002/dc.23930. Epub 2018 Mar 23.
10
High-volume workflow and performance comparisons for Chlamydia trachomatis and Neisseria gonorrhoeae testing using automated molecular platforms.使用自动化分子平台进行沙眼衣原体和淋病奈瑟菌检测的大容量工作流程和性能比较。
BMC Infect Dis. 2019 Sep 11;19(1):797. doi: 10.1186/s12879-019-4442-0.

引用本文的文献

1
False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.宫颈癌筛查中的假阴性结果——风险、原因及对临床实践和公共卫生的影响
Diagnostics (Basel). 2022 Jun 20;12(6):1508. doi: 10.3390/diagnostics12061508.
2
Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program.采用高通量 COR 仪器对 Onclarity 检测进行方法迁移后,对丹麦宫颈癌筛查项目中的 SurePath 筛查样本进行临床验证。
Am J Clin Pathol. 2022 Mar 3;157(3):390-398. doi: 10.1093/ajcp/aqab138.